Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors.
Xu, Qing-Yu
Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors. [electronic resource] - Chinese medical journal Mar 2020 - 699-715 p. digital
Publication Type: Journal Article; Review
2542-5641
10.1097/CM9.0000000000000685 doi
DNA Methylation--drug effects
Epigenesis, Genetic--drug effects
Histone Deacetylase Inhibitors--therapeutic use
Humans
Leukemia, Myeloid, Acute--drug therapy
Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors. [electronic resource] - Chinese medical journal Mar 2020 - 699-715 p. digital
Publication Type: Journal Article; Review
2542-5641
10.1097/CM9.0000000000000685 doi
DNA Methylation--drug effects
Epigenesis, Genetic--drug effects
Histone Deacetylase Inhibitors--therapeutic use
Humans
Leukemia, Myeloid, Acute--drug therapy